Comparative immunotherapeutic effect of concanavalin A and neuraminidase-treated cancer cells.
D000230:Adenocarcinoma / Q000188:drug therapy*; D000818:Animals; D003208:Concanavalin A / Q000627:therapeutic use*; D005260:Female; D005354:Fibrosarcoma / Q000139:chemically induced / Q000188:drug therapy*; D007167:Immunotherapy; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy*; D008748:Methylcholanthrene; D051379:Mice; D008809:Mice, Inbred C3H; D008810:Mice, Inbred C57BL; D008937:Mitomycins / Q000627:therapeutic use; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D009439:Neuraminidase / Q000627:therapeutic use*; D012513:Sarcoma, Experimental; D014184:Transplantation, Homologous; D014734:Vibrio cholerae / Q000201:enzymology
D008937:Mitomycins; D003208:Concanavalin A; D008748:Methylcholanthrene; D009439:Neuraminidase